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Abstract
The Female Sexual Function Index (FSFI) is a psychometrically sound and popular 19-item self-
report measure, but its length may preclude its use in studies with multiple outcome measures, 
especially when sexual function is not a primary endpoint. Only one attempt has been made to 
create a shorter scale, resulting in the Italian FSFI-6, later translated into Spanish and Korean 
without further psychometric analysis. Our study evaluated whether a subset of items on the 19-
item English-language FSFI would perform as well as the full-length FSFI in peri- and post-
menopausal women. We used baseline data from 898 peri- and post-menopausal women recruited 
from multiple communities, ages 42–62 years, and enrolled in randomized controlled trials for 
vasomotor symptom management. Goals were to (1) create a psychometrically sound, shorter 
version of the FSFI for use in peri- and post-menopausal women as a continuous measure and (2) 
compare it to the Italian FSFI-6. Results indicated that a 9-item scale provided more information 
than the FSFI-6 across a spectrum of sexual functioning, was able to capture sample variability, 
and showed sufficient range without floor or ceiling effects. All but one of the items from the 
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Italian 6-item version were included in the 9-item version. Most omitted FSFI items focused on 
frequency of events or experiences. When assessment of sexual function is a secondary endpoint 
and subject burden related to questionnaire length is a priority, the 9-item FSFI may provide 
important information about sexual function in English-speaking peri- and post-menopausal 
women.
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Sexual function is an important component of peri- and post-menopausal women’s 
menopausal quality of life. The 19-item Female Sexual Function Index (FSFI) is one 
measure that has been popular worldwide. Originally developed in English (Rosen et al., 
2000), the scale has been translated into multiple languages (Chang, Chang, Chen, & Lin, 
2009; Fakhri, Pakpour, Burri, Morshedi, & Zeidi, 2012; Filocamo et al., 2013; Ghassamia, 
Asghari, Shaeiri, & Safarinejad, 2013; Giraldo et al., 2012; Kriston, Gunzler, Rohde, & 
Berner, 2010; Nowosielski, Wrobel, Sioma-Markowska, & Poreba, 2013; Sidi, Abdullah, 
Puteh, & Midin, 2007; Sun, Li, Jin, Fan, & Wang, 2011; Takahashi, Inokuchi, Watanabe, 
Saito, & Kai, 2011). FSFI questions are coded from 0.0 to 5.0. Based on clinical 
considerations, the scale is considered to have six sexual domains (desire, arousal, 
lubrication, orgasm, satisfaction, pain), each contributing to the overarching construct of 
female sexual function (Opperman, Benson, & Milhausen, 2013; Rosen et al., 2000). The 
maximum score for each domain is 6.0, obtained by summing item responses and 
multiplying by a correction factor. The total composite sexual function score is a sum of 
domain scores and ranges from 2.0 (not sexually active and no desire) to 36.0.
The FSFI has demonstrated reliability and validity in a variety of populations. A total score 
of 26.55 was identified as the threshold for differentiating those with and without sexual 
dysfunction in a sample of 568 women, 66% of whom were premenopausal (Wiegel, 
Meston, & Rosen, 2005). Use of the measure in postmenopausal women suggests that a 
lower threshold of 20 may be appropriate for identifying women with low sexual function 
(Reed et al., 2012; Reed et al., 2014). In addition, a sexual desire domain score of 5.0 or less 
has been suggested as a threshold for hypoactive sexual desire disorder (Gerstenberger et al., 
2010).
Despite being widely used, psychometrically sound, and clinically interpretable, the full 
FSFI may be too long for use in research utilizing long assessment batteries, especially when 
assessing sexual function is not a principal goal of a study. A PubMed search using the 
keywords “FSFI and (validation or psychometrics)” produced 61 references, none of which 
focused on psychometric testing to produce a shorter English-language FSFI. However, three 
articles did pertain to non-English language FSFI versions. A shorter 6-item Italian-language 
FSFI was first developed by Isidori et al. (2010). Participants included 160 Italian women 
ages 21–49 who reported sexual activity in the past month and participated in two research 
sessions. The women were recruited from outpatient sexual and reproductive medicine 
clinics, and they completed a 19-item Italian FSFI along with a complete medical 
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consultation and physical examination. Based on receiver operating curves (ROC) generated 
for each individual item, a 6-item version was created using one item from each of the 
original six domains (desire, arousal, lubrication, orgasm, satisfaction, and pain) in the FSFI, 
with response options from 1 = poor function to 5 = optimal function for all questions and 
an additional 0 response for four questions to indicate no sexual activity in the past month. 
An FSFI score of ≤ 19.0 showed excellent sensitivity and specificity in identifying women 
with sexual dysfunction, as assessed by the full-length FSFI and medical examination, which 
demonstrated 100% convergence. Cronbach’s alpha was 0.79, and test-retest reliability at 18 
to 24 days was high (r = 0.95, p < .0001). The FSFI-6 was subsequently translated into 
Spanish (Chedraui et al., 2012; Perez-Lopez, Fernandez-Alonso, Trabalon-Pastor, Vara, & 
Chedraui, 2012) and Korean (Lee et al., 2014). These versions demonstrated strong internal 
consistency reliability (α = 0.91) but their validity was not assessed.
The purpose of our analysis was to evaluate how well a subset of items from the English-
language 19-item FSFI (Rosen et al., 2000) performed in peri- and post-menopausal women 
enrolled in treatment trials for hot flashes. We sought to develop a short English-language 
form using modern psychometric methods to maximize measurement information while 
reducing participant burden. To address the need for a shorter English-language scale and 
the limitations of Isidori et al.’s (2010) methods (e.g., small sample size and reliance on 19 
separate analyses), we performed an item response theory analysis on baseline data from 
898 peri- and post-menopausal women who participated in trials conducted within the multi-
site Menopause Strategies: Lasting Answers to Symptoms and Health (MsFLASH) research 
network. Goals of the analysis were to (1) create a psychometrically sound, shorter version 
of the FSFI for use with peri- and post-menopausal women that could be used as a single 
continuous measure for secondary outcomes and (2) compare it to the previously devised 6-
item version (Isidori et al., 2010).
Method
Design, Setting, and Sample
This was a cross-sectional analysis using baseline data from 898 peri- and post-menopausal, 
community-dwelling women reporting hot flashes who participated in MsFLASH trials 01, 
02, and 03. The full details of these trials have been reported elsewhere (Cohen et al., 2014; 
Freeman et al., 2011; Joffe et al., 2014; Newton, Reed, et al., 2014; Sternfeld et al., 2014). 
Briefly, the trials were designed to evaluate pharmaceutical, nutraceutical, and behavioral 
interventions for menopausal hot flash management (Newton, Carpenter, et al., 2014; 
Sternfeld et al., 2013). Trial 01 was a multi-site, randomized, placebo-controlled, double-
blind trial comparing escitalopram to placebo in African-American and white women. Trial 
02 was a multi-site, three by two factorial, randomized, controlled trial evaluating exercise, 
yoga, or usual activity and omega-three fatty acid supplements or placebo. Trial 03 was a 
multi-site, randomized, placebo-controlled, double-blind trial of low dose 17-beta-estradiol, 
venlafaxine, or placebo.
All studies were approved by institutional review boards at the Data Coordinating Center 
(Seattle) and the participating clinical sites. Participants were recruited mainly through mass 
mailings to age-eligible women using health-plan enrollment data and purchased mailing 
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lists. All participants in all studies provided written informed consent and signed 
authorization to use protected health information. Common to all trials, participants were: 
aged 40 to 62; peri- or post-menopausal; in good general health based on self-report, vital 
signs, and blood tests; not using treatments for hot flashes; and reporting no drug or alcohol 
abuse in the past year or a major depressive episode in the past three months. Eligible 
women reported frequent weekly hot flashes (≥ 28 per week in trial 01, ≥ 14 in trials 02 and 
03) that were bothersome or severe on four or more days or nights per week. Women were 
enrolled from clinical sites located in Boston, Indianapolis, Oakland, Philadelphia, and 
Seattle. All data analyzed here were collected during the baseline, pre-randomization trial 
periods.
Measures
The 19-item FSFI was included in a larger questionnaire battery administered at baseline 
and post-intervention. It was disproportionately longer compared to other scales used to 
measure other symptoms and experiences (Newton, Carpenter, et al., 2014) which resulted in 
questions from participants about its importance. Sexual functioning over the past four 
weeks was evaluated (Rosen et al., 2000). The standard formula-based scoring was used to 
obtain total scores ranging from 2.0 to 36.0 and domain scores ranging from 0.8 to 6.0 for 
satisfaction, 1.2 to 6.0 for desire, and 0.0 to 6.0 for arousal, lubrication, orgasm, and pain. 
Domain scores of 0.0 indicate no sexual activity during the past month. Higher domain and 
total scores indicate more optimal sexual functioning.
To determine how bothered or distressed women were by their levels of sexual function, we 
adapted a single question from the Female Sexual Distress Scale: “In the past four weeks, 
how often did you feel distressed or bothered about your sex life?” Scoring was: 0 = never, 1 
= rarely, 2 = occasionally, 3 = frequently, and 4 = always (Derogatis, Rosen, Leiblum, 
Burnett, & Heiman, 2002).
Baseline demographic characteristics collected from all women included age, race, ethnicity, 
menopausal status, education, and income. Height and weight were collected in clinic by 
study staff to calculate body mass index.
Data Analysis
After sample demographics and scale scores were analyzed using descriptive statistics, item 
response theory (IRT) was the main analysis method. Analyses were conducted with 
IRTPRO 2.0 (Scientific Software International, 2013). Psychometric analyses using IRT are 
model-based, estimating the probability of item responses as a function of the level of the 
underlying construct being measured (Hambleton & Swaminathan, 1985). Items are 
“calibrated” using IRT models, yielding parameter estimates that characterize item-level 
measurement performance. These parameter estimates can be generalized via linear 
transformation from one sample to another from the same population, unlike psychometric 
indices obtained via traditional classical test theory methods (e.g., summed score), which are 
limited to the samples investigated. With 500–1,000 people sampled (Reise & Yu, 1990), the 
idea with IRT is that stable item parameters can be estimated, facilitating estimation of 
individuals’ IRT scores. The use of IRT and IRT scores is suggested as an alternative to 
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avoid many of the pitfalls of short-form development, including the need to evaluate in 
another sample, since the selected items are specifically chosen because of their accurate 
measurement of targeted levels of the underlying construct (Smith, McCarthy, & Anderson, 
2000).
Another advantage of IRT is its ability to handle missing data (Bock & Aitkin, 1981; Lord, 
1980). Because analyses focus on estimating item properties rather than participant 
characteristics, when participants miss or skip a particular item, their responses to other 
items are still preserved and used. In MsFLASH 01 (n = 195), one of the FSFI satisfaction 
questions was inadvertently missing. This single question, one of three questions in the 
satisfaction domain, was: “Over the past four weeks, how satisfied have you been with your 
overall sex life?” For examining descriptive scale scores, we used a mean imputation where 
item scores were imputed as an average of the answers to the two other questions in the FSFI 
satisfaction domain. Imputed scores were not used for the IRT analysis (Bock & Aitkin, 
1981; Lord, 1980). All women were included in the IRT analyses; however, items for which 
they reported no sexual activity were coded as missing, not as numerical values.
The IRT models used in this study calculate two types of parameters for each item: difficulty 
and discrimination (Hays, Morales, & Reise, 2000). Difficulty parameters (represented by b) 
show what level of a trait or construct an item best measures; for example, in this study 
“easy” items (or those with low difficulty parameters) provide the most information in 
measuring lower female sexual functioning, whereas “difficult” items (or those with high 
difficulty parameters) provide the most information in measuring better female sexual 
functioning. In the case of items with multiple response options, such as those in the FSFI, 
several difficulty parameters are calculated, specifically, one fewer than the number of 
response options (Samejima, 1969). Difficulty parameter b1 represents the level of sexual 
functioning required for a randomly selected participant to select response option 1 instead 
of 0; difficulty parameter b2 represents the level of sexual functioning required for a 
randomly selected participant to select response option 2 rather than 1, and so on. 
Discrimination parameters (represented by a) reveal how accurately an item measures the 
underlying construct at its difficulty level. For example, if items X and Y have very similar 
difficulty parameter estimates, but item X has a higher discrimination parameter than item Y, 
then item X provides more discrimination among participants with sexual function near 
those difficulty levels than item Y.
Using these parameters, IRT analyses determine the amount of measurement information 
each item provides at specific levels of the underlying construct of interest (i.e., female 
sexual functioning). Information levels can be interpreted as the degree of measurement 
precision provided by an item at various levels of the underlying construct (e.g., a screening 
measure should provide the most information around the screening point, whereas an 
instrument intended to measure the full range of a construct should provide high levels of 
information along the entire continuum). Careful consideration of estimates of item 
difficulty, discrimination, and information can facilitate instrument development by guiding 
selection of items that are most informative at specified levels of the construct of interest. 
Thus, IRT analyses can be used to (1) reduce respondent burden by eliminating unnecessary 
or redundant items (e.g., the item Y described above would be considered redundant), (2) 
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ensure reliable measurement of the latent construct along its entire continuum by eliminating 
items leading to floor or ceiling effects, and (3) ensure reliable measurement at specific 
points at which more precision is needed.
The IRT analyses of the FSFI included: (a) fitting an appropriate IRT model (the graded 
response model) (Samejima, 1969) to the ordinal-level data capturing participant responses 
to each item; (b) calibrating the items to obtain item difficulty parameters, item 
discrimination parameters, and item information estimates; and (c) identifying the subset of 
items that simultaneously maximized the scale’s measurement information along the 
spectrum of female sexual functioning while minimizing the number of items required in the 
scale. We utilized the IRT analyses to create a short form of the FSFI with the a priori 
requirement that at least one item from each facet of female sexual function (desire, arousal, 
lubrication, orgasm, satisfaction and pain) was included to ensure adequate coverage of the 
construct, as was done by a previous team (Isidori et al., 2010). To create a shorter version of 
the FSFI that could be used for rapid assessment, we aimed to select a set of items that 
would be informative at different levels of sexual functioning, both above and below the 
sample mean.
Following item selection, we converted participants’ IRT scores obtained with IRTPRO 2.0 
to summed scale scores for the set of selected items using the test characteristic curve. The 
test characteristic curve plots the IRT scores on the x-axis against the traditional summed 
scores on the y-axis. To compare sexual functioning scores to sexual distress, we first 
classified participants responding “frequently” or “always” on the sexual distress item as 
having high sexual distress. We then created three different categorizations of sexual 
functioning using the summed scale scores equivalent to IRT scores of −0.5, −1.0, and −1.5, 
with participants scoring below each of these points classified as having low sexual 
functioning and those scoring above as having high sexual functioning. Finally, we 
examined the associations between sexual distress (1 = high, 0 = low) and each of the three 
categorizations of sexual functioning (1 = high, 0 = low) using chi-square tests.
Results
Consistent with the parent trials’ inclusion criteria, the 898 women in the sample were on 
average 54.47 years of age (SD 3.83). Most were married or living with a partner (63.2%), 
had completed a bachelor’s degree or higher (52.7%), and were employed full or part time 
(69.7%). Across all three studies, 62.4% were Caucasian, 33.9% African American, 2.8% 
Hispanic, 2.0% Native American, 2.3% Asian American, and 3.3% another race/ethnicity. 
Women in the sample were 18.1% perimenopausal and 81.9% postmenopausal. Most 
(74.4%) reported at least some sexual activity on the FSFI.
Item Response Theory Analyses
The initial IRT model using all 19 items of the FSFI resulted in significant S-χ2 values for 
the four arousal items (all p < 0.0001 with Bonferroni-corrected alpha of 0.003), indicating 
violation of the local independence assumption of IRT. Thus, only item 5 (level of sexual 
arousal during sexual activity or intercourse) was retained in the model since this aspect of 
female sexual function was deemed important to assess. We chose this item because it 
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showed the best ability to identify female sexual dysfunction in the study that developed the 
previous short form (Isidori et al., 2010). We then ran the IRT model again on the remaining 
16 items, and the local independence assumption did not appear to be violated (all p > 0.01 
with a Bonferroni-corrected alpha of 0.003).
As would be expected, the 16 remaining items from the FSFI had a range of difficulty and 
discrimination parameter estimates (Table 1). Between the two desire items (items 1 and 2), 
we chose item 2 because it had better discrimination and measured a wider range of the 
construct as shown by the difficulty parameters. For arousal, we used item 5 for the same 
reasons. For lubrication (items 7 to 10), we selected items 8 and 9 because they provided 
better discrimination than item 10 and together measured a greater range of sexual function 
than item 7. For orgasm (items 11–13), we eliminated item 13 because of its narrow 
measurement range and included items 11 and 12 because both had wider coverage of the 
construct than item 13. For satisfaction (items 14, 18, and 19), we included items 14 and 19 
because item 14 was one of the few items to measure very low levels of the construct and 
item 19 was one of the few items to measure very high levels of the construct. For pain 
(items 15–17), we included item 17 because it was one of the few items measuring very low 
levels of sexual function. This created a 9-item measure that could assess most levels of the 
construct without requiring all 19 items. Of note, 5 of the 6 items from the previous Italian 
short form (Isidori et al., 2010) were included in the 9-item measure. Descriptive statistics 
for the three versions of the FSFI (full scale, 9-item, and 6-item) are shown in Table 2.
Because of the IRT assumption of local independence, the information offered by a given set 
of items can be determined by simply adding the information levels of the individual items 
comprising the set. This cumulative information is referred to as test-level information, and 
we examined it for each version of the scale (Figure 1) to visually compare the amount and 
distribution of measurement information offered by each. As would be expected, the 16 
items provided more information than either the 9-item scale or the 6-item scale (Isidori et 
al., 2010). However, the 9-item scale provided more information (i.e., had less error and 
greater precision) at all levels of sexual function than the 6-item scale. This was particularly 
evident from 1.5 standard deviations below the mean to 1.5 standard deviations above the 
mean.
Sexual Functioning Groups
The test characteristic curve for the 9-item short form (Figure 2) shows the corresponding 
summed score for each IRT score. A score 1.5 standard deviations below the mean (IRT 
score of −1.5) corresponded to a score of 6.5 on the 9-item short form. An IRT score of −1.0 
corresponded to a scale score of 10, and an IRT score of −0.5 corresponded to a score of 
15.0.
We then compared the scores on the 9-item short form to the sexual distress item. Only the 
599 participants from trials 02 and 03 were included in these descriptive analyses – women 
from the first study were excluded because of the missing item problem described above. 
Women who reported low sexual function on the 9-item short form had significantly higher 
distress due to sexual function than women with high sexual function using scores of 15.0 
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(χ2 = 19.69, p < 0.001), of 10.0 (χ2 = 7.41, p = 0.01) and of 7.0 (χ2 = 6.56, p = 0.01) (Table 
3).
Discussion
Using data from a sample of community-dwelling peri- and post-menopausal women 
experiencing hot flashes, we created a 9-item version of the FSFI. The 9-item version 
provided information across the entire spectrum of sexual functioning, and descriptive 
statistics showed it was able to capture variability within the sample (e.g., large standard 
deviations) and had sufficient range.
The test-level information provided by the new 9-item scale proposed here points to the 
relative importance of the scale. Although our PubMed search revealed that the FSFI has 
been widely used and is psychometrically sound, we found only one psychometric analysis 
that was performed in an attempt to create a shorter scale. The prior work by Isidori et al. 
(2010) led to subsequent translations of the 6-item version without further psychometric 
analysis. All but one of the items from the 6-item version were included in the 9-item 
version. The one exception was the sexual arousal item pertaining to how often a woman 
reported that she became lubricated (“wet”) during sexual activity or intercourse. Being able 
to maintain lubrication and not having difficulty becoming lubricated were found to be more 
informative items. These items may have been particularly important for our peri- and post-
menopausal sample because of their unique patterns of symptoms related to hormonal 
changes; thus, findings need to be replicated in other age groups.
An unexpected finding was that, overall, most of the items omitted from the full FSFI in 
developing both the 9-item and prior 6-item versions were those measuring the frequency of 
an event or experience. In our sample of peri- and post-menopausal women, sexual 
frequency over the past month may have been a relatively less accurate measure of female 
sexual function since it also reflects partner desire and physical capability and/or a couple’s 
typical sexual behavior patterns (Adams, Gold, & Burt, 1978). It is estimated that 52% of 
American men aged 40–70 years are affected by some degree of erectile dysfunction 
(O’Donnell, Araujo, & McKinlay, 2004). Although not a preconceived study hypothesis, 
results of the IRT-guided selection of items may point to the relatively greater importance of 
severity and difficulty of experiences, rather than frequency, for assessing peri- and post-
menopausal women’s sexual functioning. A frequency of no sexual activity is assigned a 
score of 0, which would only correctly reflect the lowest sexual functioning if the lack of 
sexual activity was related to the symptoms assessed by the items and not to other reasons 
(Baser, Li, & Carter, 2012). This finding should be explored further, since its implications 
may be important in clinical trials and other treatment studies that aim to use the FSFI as an 
outcome.
Findings from two previous studies may provide context for the arousal items showing local 
dependence in our analysis. The original measurement model (n = 259 women) yielded a 5-
factor solution, with the arousal items actually loading onto the desire factor, but six factors 
were retained for “clinical considerations” (Rosen et al., 2000). In a subsequent paper 
published in 2013, the authors compared several models of the FSFI, including a 6-factor 
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model as originally suggested and a 5-factor model combining the desire and arousal 
subscales (n = 85 women) (Opperman et al., 2013). Both the 5- and 6-factor models were 
supported (Opperman et al., 2013). Combining desire and arousal is consistent with DSM-5 
changes in definitions of female sexual dysfunctions (American Psychiatric Association, 
2013). Desire and arousal disorders are now combined into a single disorder, female sexual 
interest/arousal disorder, since the distinction between these phases of the sexual response 
cycle may be artificial. That desire and arousal in female sexual function are so closely 
related could explain the problems with the arousal items in our initial analyses, although it 
should be noted that the intention of this study was not to examine the latent structure of 
female sexual function.
Our findings suggest that, when a shorter FSFI is desired in peri- and post-menopausal 
samples experiencing hot flashes, the 9-item version may be advantageous for use as a 
single, continuous measure, particularly when participant burden is a consideration. The 9-
item version demonstrated the ability to differentiate between peri- and post-menopausal 
women categorized by self-reported levels of sexual function and sexual function with 
distress, using three different potential categorizations of low versus high sexual functioning. 
However, our results were based only on known groups validity with groups defined as high 
versus low sexual functioning. We avoided the terms sexually functional and sexually 
dysfunctional, because a gold standard for assessment of sexual function such as a clinical 
interview by an expert in sexual function was not performed in this study. Further evaluation 
with a gold standard sexual function assessment will be beneficial.
Differences in items selected for our shortened FSFI scale versus Isidori et al.’s (2010) 6-
item Italian version may be at least partially explained by differences in the populations 
studied and analytic methods. Our population was older (mean age 54.49 vs. 34.9), focused 
on peri- and post-menopausal women (100% vs. 4%), and largely recruited from the 
community rather than during clinical visits. In addition, our IRT analysis differed from the 
classical test theory approach used by Isidori and colleagues, which relied solely on sample-
dependent summed score methods.
Study findings should be interpreted in view of the following study limitations. An 
assessment of sexual activity, partner gender, and history of physical and sexual abuse was 
conducted in trial 03 only. Therefore, these data were not available for the majority of 
women included in this analysis. In addition, findings are generalizable to a population of 
symptomatic peri- and post-menopausal women, but should be interpreted cautiously or 
replicated in women of different ages and different medical conditions. Our population of 
peri- and post-menopausal women may have had particular symptoms that affected sexual 
functioning such as vaginal dryness and subsequent dyspareunia, but the women were not 
recruited based on sexual function and vaginal dryness, which are only marginally linked to 
hot flashes (Carpenter et al., 2015). Our findings also reflect a population experiencing hot 
flashes and may not generalize to the minority 20% of women who do not experience this 
cardinal menopausal symptom. The FSFI does not assess women’s bother or concern related 
to sexual function. This could explain why a fairly large minority of women reporting high 
sexual function also reported distress. Finally, we were not able to compare short-version 
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summed scores to an external criterion such as a clinical interview, the gold standard for 
assessing female sexual dysfunction.
In summary, IRT analyses guided the development of a 9-item English-language version of 
the FSFI that was more informative when used with peri- and post-menopausal women 
experiencing hot flashes than a previously developed 6-item Italian version. In studies in 
which sexual function is the primary outcome measure, the 19-item FSFI should be used 
since it is the most informative. When assessment of sexual function is just one of many 
secondary endpoints and subject burden related to questionnaire length is a priority, this 
shorter version of the FSFI may allow researchers to obtain important information on sexual 
function in peri- and post-menopausal women experiencing hot flashes.
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Figure 1. 
Test-Level Information Curves for Each Version of the Female Sexual Function Index. 
Legend: For level of sexual function, 0 represents the mean and the standard deviation is 1. 
Higher levels of information indicate more precise measurement.
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Figure 2. 
Test Characteristic Curve for FSFI-9 Item
This curve shows the conversion of each item response theory (IRT) score (mean of 0 and 
standard deviation of 1) to the corresponding 9-item FSFI summed score (ranges from 2 to 
45). For example, an IRT score of 0 corresponds to a summed score of about 20 and an IRT 
score of −0.5 corresponds to a summed score of 15.
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Table 2
Descriptive Statistics for the Three Versions of the Female Sexual Function Index (FSFI)
Possible range Actual range Mean Standard Deviation
19-item full scale 1.2 – 36.0 1.2 – 36.0 18.2 10.9
9-item short form 2.0 – 45.0 2.0 – 45.0 22.5 13.7
6-item short forma 2.0 – 30.0 2.0 – 30.0 14.9 8.4
Note.
a
Isidori et al. (2010); Possible score range for the 19-item full scale uses a formula with a maximum of 6 points in each of 6 domains, with each 
domain having a different number of items; possible score range for 9- and 6-item versions uses sum of items.
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